Home › Craniopharyngioma
Craniopharyngioma clinical trials recruiting in the U.S.
5 studies for Craniopharyngioma are recruiting participants at sites across the United States.
Cities with the most studies
By state
- Colorado3 studies
- District of Columbia3 studies
- Florida3 studies
- North Carolina3 studies
- Ohio3 studies
- Pennsylvania3 studies
Recently updated studies
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Apr 23, 2026 · NCT05465174ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Apr 23, 2026 · NCT05233397MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Apr 8, 2026 · NCT05286788Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
RecruitingPhase 2Mentions payment for participants
Ages 6 to 28 · All sexes · Updated Jul 28, 2025 · NCT06299891From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.